Pomanda estimates the enterprise value of XEINADIN NORTH LIMITED at £1.7m based on a Turnover of £2m and 0.83x industry multiple (adjusted for size and gross margin).
xeinadin north limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of XEINADIN NORTH LIMITED at £0 based on an EBITDA of £-304k and a 4.99x industry multiple (adjusted for size and gross margin).
xeinadin north limitedEstimated Valuation
£3.6m
Pomanda estimates the enterprise value of XEINADIN NORTH LIMITED at £3.6m based on Net Assets of £1.2m and 3.03x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Xeinadin North LimitedOverview
Xeinadin North Limited is a live company located in manchester, M2 3BD with a Companies House number of 11404925. It operates in the accounting and auditing activities sector, SIC Code 69201. Founded in June 2018, it's largest shareholder is
xeinadin uk professional services ltd
with a 51.2% stake. Xeinadin North Limited is a young,
small sized company, Pomanda has estimated its turnover at
£2m with
healthy
growth in recent years.
Pomanda's financial health check has awarded Xeinadin North Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
4 Strong
3 Regular
4 Weak
Size
annual sales of £2m, make it larger than the average company (£194.1k)
£2m - Xeinadin North Limited
£194.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 7%, show it is growing at a similar rate (8.9%)
7% - Xeinadin North Limited
8.9% - Industry AVG
Production
with a gross margin of 52.1%, this company has a higher cost of product (94.1%)
52.1% - Xeinadin North Limited
94.1% - Industry AVG
Profitability
an operating margin of -17.7% make it less profitable than the average company (7.2%)
-17.7% - Xeinadin North Limited
7.2% - Industry AVG
Employees
with 26 employees, this is above the industry average (3)
26 - Xeinadin North Limited
3 - Industry AVG
Pay Structure
on an average salary of £37.2k, the company has an equivalent pay structure (£37.2k)
£37.2k - Xeinadin North Limited
£37.2k - Industry AVG
Efficiency
resulting in sales per employee of £78.7k, this is equally as efficient (£78.9k)
£78.7k - Xeinadin North Limited
£78.9k - Industry AVG
Debtor Days
it gets paid by customers after 185 days, this is later than average (73 days)
185 days - Xeinadin North Limited
73 days - Industry AVG
Creditor Days
its suppliers are paid after 139 days, this is slower than average (24 days)
139 days - Xeinadin North Limited
24 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Xeinadin North Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 7 weeks, this is less cash available to meet short term requirements (29 weeks)
7 weeks - Xeinadin North Limited
29 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 38.4%, this is a lower level of debt than the average (51.1%)
38.4% - Xeinadin North Limited
51.1% - Industry AVG
XEINADIN NORTH LIMITED financials
EXPORT
Xeinadin North Limited's latest turnover from May 2024 is estimated at £2 million and the company has net assets of £1.2 million. According to their latest financial statements, Xeinadin North Limited has 26 employees and maintains cash reserves of £96.1 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
May 2024
May 2023
May 2022
May 2021
May 2020
May 2019
Turnover
2,046,358
1,540,902
1,600,894
1,648,553
2,565,269
Other Income Or Grants
Cost Of Sales
979,523
731,537
726,214
722,786
906,740
Gross Profit
1,066,835
809,366
874,680
925,767
1,658,529
Admin Expenses
1,428,173
1,146,058
-405,547
1,156,151
334,665
Operating Profit
-361,338
-336,692
1,280,227
-230,384
1,323,864
Interest Payable
41
Interest Receivable
3,493
6,937
9,189
990
46
Pre-Tax Profit
-357,845
-329,755
1,289,416
-229,394
1,323,869
Tax
-244,989
-251,824
Profit After Tax
-357,845
-329,755
1,044,427
-229,394
1,072,045
Dividends Paid
Retained Profit
-357,845
-329,755
1,044,427
-229,394
1,072,045
Employee Costs
965,912
839,053
799,079
727,751
837,938
Number Of Employees
26
24
24
24
23
EBITDA*
-303,988
-279,475
1,321,211
-190,534
1,324,922
* Earnings Before Interest, Tax, Depreciation and Amortisation
May 2024
May 2023
May 2022
May 2021
May 2020
May 2019
Tangible Assets
9,744
4,562
121,243
158,747
3,422
Intangible Assets
214,952
103,080
Investments & Other
1
1
1
1
1
Debtors (Due After 1 year)
Total Fixed Assets
224,697
107,643
121,244
158,748
3,423
Stock & work in progress
Trade Debtors
1,041,543
772,362
867,843
927,655
880,736
Group Debtors
438,210
695,963
1,514,210
Misc Debtors
145,848
556,189
48,426
91,755
477,100
Cash
96,118
36,961
271,362
1,566,414
413,369
misc current assets
22,094
total current assets
1,721,719
2,061,475
2,701,841
2,607,918
1,771,205
total assets
1,946,416
2,169,118
2,823,085
2,766,666
1,774,628
Bank overdraft
Bank loan
Trade Creditors
373,774
347,931
638,949
675,195
25,404
Group/Directors Accounts
400,000
other short term finances
hp & lease commitments
41,402
39,422
37,553
35,765
other current liabilities
284,338
181,489
176,697
694,266
676,119
total current liabilities
699,514
568,842
853,199
1,805,226
701,523
loans
hp & lease commitments
41,402
80,826
118,379
Accruals and Deferred Income
other liabilities
provisions
47,014
1,141
1,572
650
total long term liabilities
47,014
42,543
82,398
118,379
650
total liabilities
746,528
611,385
935,597
1,923,605
702,173
net assets
1,199,888
1,557,733
1,887,488
843,061
1,072,455
total shareholders funds
1,199,888
1,557,733
1,887,488
843,061
1,072,455
May 2024
May 2023
May 2022
May 2021
May 2020
May 2019
Operating Activities
Operating Profit
-361,338
-336,692
1,280,227
-230,384
1,323,864
Depreciation
41,503
41,370
40,984
39,850
1,058
Amortisation
15,847
15,847
Tax
-244,989
-251,824
Stock
Debtors
-398,913
-405,965
1,411,069
-338,426
1,357,836
Creditors
25,843
-291,018
-36,246
649,791
25,404
Accruals and Deferred Income
102,849
4,792
-517,569
18,147
676,119
Deferred Taxes & Provisions
45,873
-431
1,572
-650
650
Cash flow from operations
269,490
-160,167
-887,090
815,180
417,435
Investing Activities
capital expenditure
-174,404
-43,616
-3,480
-195,175
-4,480
Change in Investments
1
cash flow from investments
-174,404
-43,616
-3,480
-195,175
-4,481
Financing Activities
Bank loans
Group/Directors Accounts
-400,000
400,000
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
-39,422
-37,555
-35,765
154,144
other long term liabilities
share issue
410
interest
3,493
6,937
9,189
990
5
cash flow from financing
-35,929
-30,618
-426,576
555,134
415
cash and cash equivalents
cash
59,157
-234,401
-1,295,052
1,153,045
413,369
overdraft
change in cash
59,157
-234,401
-1,295,052
1,153,045
413,369
xeinadin north limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for xeinadin north limited. Get real-time insights into xeinadin north limited's credit score, group structure and payment trends.
Perform a competitor analysis for xeinadin north limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in M 2 area or any other competitors across 12 key performance metrics.
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to xeinadin north limited. Currently there are 1 open charges and 0 have been satisfied in the past.
xeinadin north limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for XEINADIN NORTH LIMITED. This can take several minutes, an email will notify you when this has completed.
xeinadin north limitedCompanies House Filings - See Documents
